Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$165.67 - $199.94 $635,013 - $766,370
-3,833 Reduced 99.97%
1 $0
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $560,025 - $739,932
3,698 Added 2719.12%
3,834 $756,000
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $21,726 - $25,141
135 Added 13500.0%
136 $23,000
Q4 2022

Feb 03, 2023

BUY
$131.14 - $157.47 $131 - $157
1 New
1 $0
Q2 2022

Jul 18, 2022

BUY
$155.97 - $200.09 $2,495 - $3,201
16 New
16 $3,000
Q4 2021

Jan 21, 2022

SELL
$193.69 - $247.03 $5,035 - $6,422
-26 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$189.29 - $209.69 $4,921 - $5,451
26 New
26 $5,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Tfo Tdc, LLC Portfolio

Follow Tfo Tdc, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfo Tdc, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tfo Tdc, LLC with notifications on news.